Replies to post #79259 on Biotech Values

[DewDiligence]

JNJ has withdrawn Evolence from the US market. (Source: 3Q09 MRX CC.)

What went wrong? Despite JNJ’s marketing heft, Restylane/Perlane and Juvederm are too entrenched and Radiesse is too efficacious for a me-too dermal filler to make much headway.